Risk of hepatitis C virus transmission through drug preparation equipment: A systematic and methodological review

Journal of Viral Hepatitis

Volumn 15, Issue 4, 2008, Pages 279-292

  De, P ^a,b   Roy, E ^b,c,d,e   Boivin, J F ^b,d   Cox, J ^b,c,d   Morissette, C ^b,d  

^a Division of Infectious Diseases   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^d Montreal Public Health Department   (Canada)

^e UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Hepatitis C; HIV; Injecting paraphernalia; Injection drug use; Syringes

Indexed keywords

CASE CONTROL STUDY; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONFOUNDING VARIABLE; CONTAINER; DATA BASE; DRUG SYNTHESIS; DRUG USE; FILTER; FOLLOW UP; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; INJECTION; METHODOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYRINGE; SYSTEMATIC REVIEW; VIRUS TRANSMISSION;

ADULT; CROSS INFECTION; EQUIPMENT CONTAMINATION; HEPATITIS C; HUMANS; INCIDENCE; RISK ASSESSMENT; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 40149083125     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2007.00942.x     Document Type: Review

References (32)

1. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005 5 : 558 567.
2. Heintges T, Wands JR. Hepatitis C virus: epidemiology and transmission. Hepatology 1997 26 : 521 526.
3. Alter MJ, Kruszon-Moran D, Nainan OV et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999 341 : 556 562.
4. Villano SA, Vlahov D, Nelson KE et al. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol 1997 35 : 3274 3277.
5. Maher L, Li J, Jalaludin B et al. High hepatitis C incidence in new injecting drug users: a policy failure? Aust N Z J Public Health 2007 31 : 30 35.
6. Garfein RS, Vlahov D, Galai N et al. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996 86 : 655 661.
7. Garten RJ, Lai S, Zhang J et al. Rapid transmission of hepatitis C virus among young injecting heroin drug users in Southern China. Int J Epidemiol 2004 33 : 182 188.
8. Maher L, Jalaludin B, Chant KG et al. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction 2006 101 : 1499 1508.
9. Koester S, Booth RE, Zhang Y. The prevalence of additional injection-related HIV risk behaviors among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1996 12 : 202 207.
10. Needle RH, Coyle S, Cesari H et al. HIV risk behaviors associated with the injection process: multiperson use of drug injection equipment and paraphernalia in injection drug user networks. Subst Use Misuse 1998 33 : 2403 2423.
11. Koester S, Heimer R, Baron AE. Risk of hepatitis C among young adult injection drug users who share injection equipment. Am J Epidemiol 2003 157 : 376.
12. Crofts N, Aitken CK, Kaldor JM. The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not. Med J Aust 1999 170 : 220 221.
13. Crofts N, Caruana S, Bowden S et al. Minimising harm from hepatitis C virus needs better strategies. BMJ 2000 321 : 899.
14. Mathei C, Shkedy Z, Denis B et al. Evidence for a substantial role of sharing of injecting paraphernalia other than syringes / needles to the spread of hepatitis C among injecting drug users. J Viral Hepat 2006 13 : 560 570.
15. Prati D. Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. J Hepatol 2006 45 : 607 616.
16. Holsen DS, Harthug S, Myrmel H. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway. Eur J Clin Microbiol Infect Dis 1993 12 : 673 676.
17. Egger M, Davey Smith G, Altman D. Systematic Reviews in Health Care: Meta Analysis in Context, 2nd edn. London : BMJ Publishing Group, 2001.
18. Thorpe LE, Ouellet LJ. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol 2002 155 : 645 653.
19. Hagan H, Thiede H, Weiss NS et al. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health 2001 91 : 42 46.
20. Lucidarme D, Bruandet A, Ilef D et al. Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France. Epidemiol Infect 2004 132 : 699 708.
21. Miller CL, Johnston C, Spittal PM et al. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology 2002 36 : 737 742.
22. Hahn JA, Page-Shafer K, Lum PJ et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis 2002 186 : 1558 1564.
23. Roy E, Alary M, Morissette C et al. High hepatitis C virus prevalence and incidence among Canadian intravenous drug users. Int J STD AIDS 2007 18 : 23 27.
24. Kapadia F, Vlahov D, Des Jarlais DC et al. Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users? Epidemiology 2002 13 : 738 741.
25. Rezza G, Sagliocca L, Zaccarelli M et al. Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence. Scand J Infect Dis 1996 28 : 27 29.
26. Becker Buxton M, Vlahov D, Strathdee SA et al. Association between injection practices and duration of injection among recently initiated injection drug users. Drug Alcohol Depend 2004 75 : 177 183.
27. Fennema JSA, van Ameijden EJC, Van den Hoek A et al. Young and recent-onset injecting drug users are at higher risk for HIV. Addiction 1997 92 : 1457 1465.
28. Baker A, Kochan N, Dixon J et al. HIV risk-taking behaviour among injecting drug users currently, previously and never enrolled in methadone treatment. Addiction 1995 90 : 545 554.
29. Latkin C, Mandell W, Vlahov D et al. People and places: behavioral settings and personal network characteristics as correlates of needle sharing. J Acquir Immune Defic Syndr Hum Retrovirol 1996 13 : 273 280.
30. Anthony JC, Vlahov D, Nelson KE et al. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Am J Epidemiol 1991 134 : 1175 1189.
31. Chaisson R, Bacchetti P, Osmond D et al. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 1989 261 : 561 565.
32. Cameron SO, Wilson KS, Good T et al. Detection of antibodies against hepatitis C virus in saliva: a marker of viral replication. J Viral Hepat 1999 6 : 141 144.